Esperion Therapeutics, Inc. (ESPR) has a market capitalization of $426.21M and trades at $2.05. The 52-week range is 0.69-4.18.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -18.6, Earnings Per Share (EPS) of $-0.11, annual revenue of $403.14M.
The stock has a beta of 1.17, operates in the Healthcare sector.
